Search research articles
Contact Us
Filters
Showing results (21-30 of 59) with videos related to
Page
of 6
Sort By:
Anticancer Research
|
July 24, 2010
Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis
Joanna Szkandera, Gudrun Knechtel, Michael Stotz, et al.
Anticancer Research
|
October 15, 2013
Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer
Gudrun Absenger, Joanna Szkandera, Michael Stotz, et al.
International Journal of Molecular Sciences
|
April 20, 2016
Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma
Maximilian Seles, Georg C Hutterer, Tobias Kiesslich, et al.
Molecular Carcinogenesis
|
June 24, 2010
Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk
Gudrun Knechtel, Joanna Szkandera, Michael Stotz, et al.
International Journal of Cancer
|
December 19, 2013
The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas
Joanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, et al.
Clinical Chemistry and Laboratory Medicine
|
November 13, 2014
The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer
Michael Stotz, Joanna Szkandera, Tatjana Stojakovic, et al.
Journal of Surgical Oncology
|
October 15, 2013
The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients
Joanna Szkandera, Martin Pichler, Bernadette Liegl-Atzwanger, et al.
Anticancer Research
|
April 5, 2017
Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients
Michael Stotz, Sereina A Herzog, Martin Pichler, et al.
Clinical Orthopaedics and Related Research
|
January 14, 2017
Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Florian Posch, Lukas Leitner, Marko Bergovec, et al.
Cancer Epidemiology
|
November 6, 2013
Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients
Joanna Szkandera, Gudrun Absenger, Bernadette Liegl-Atzwanger, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 59) with videos related to
Sort By:
Page
of 6
Anticancer Research
|
July 24, 2010
Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis
Joanna Szkandera, Gudrun Knechtel, Michael Stotz, et al.
Anticancer Research
|
October 15, 2013
Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer
Gudrun Absenger, Joanna Szkandera, Michael Stotz, et al.
International Journal of Molecular Sciences
|
April 20, 2016
Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma
Maximilian Seles, Georg C Hutterer, Tobias Kiesslich, et al.
Molecular Carcinogenesis
|
June 24, 2010
Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk
Gudrun Knechtel, Joanna Szkandera, Michael Stotz, et al.
International Journal of Cancer
|
December 19, 2013
The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas
Joanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, et al.
Clinical Chemistry and Laboratory Medicine
|
November 13, 2014
The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer
Michael Stotz, Joanna Szkandera, Tatjana Stojakovic, et al.
Journal of Surgical Oncology
|
October 15, 2013
The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients
Joanna Szkandera, Martin Pichler, Bernadette Liegl-Atzwanger, et al.
Anticancer Research
|
April 5, 2017
Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients
Michael Stotz, Sereina A Herzog, Martin Pichler, et al.
Clinical Orthopaedics and Related Research
|
January 14, 2017
Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Florian Posch, Lukas Leitner, Marko Bergovec, et al.
Cancer Epidemiology
|
November 6, 2013
Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients
Joanna Szkandera, Gudrun Absenger, Bernadette Liegl-Atzwanger, et al.
Page
of 6